SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO - News), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it has been invited to participate in a Food and Drug Administration (FDA) panel meeting to be held on September 20, 2007 from 8:00 am to 6:00 pm ET in Gaithersburg, Maryland. The FDA panel committee will discuss and make recommendations regarding clinical trial designs for cardiac ablation devices designed to treat patients with medically refractory atrial fibrillation.
